ArticleGastroenterology2015
Quality indicators for the management of Barrett's esophagus, dysplasia, and esophageal adenocarcinoma: international consensus recommendations from the American Gastroenterological Association Symposium.
Article in Gastroenterology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
34 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Quality indicators for upper GI endoscopy.Gastrointestinal endoscopy · 2025Guideline
- Quality Indicators for Upper GI Endoscopy.The American journal of gastroenterology · 2025Article
- Implementing educational interventions and key performance measures sustains quality of endoscopic assessment in patients with Barrett's esophagus.Endoscopy international open · 2025Article
- Cost-effective identification of Barrett's esophagus in the community: A first step towards screening.Journal of gastroenterology and hepatology · 2024Article
- Prevalence and Predictors of Barrett's Esophagus After Negative Initial Endoscopy: Analysis From Two National Databases.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2024Article
- Adherence to quality indicators and best practices in surveillance endoscopy of Barrett's esophagus: A video-based assessment.Endoscopy international open · 2024Article
- Impact of Residing in Below Median Household Income Districts on Outcomes in Patients with Advanced Barrett's Esophagus.Journal of the Canadian Association of Gastroenterology · 2023Article
- Natural Language Processing Can Automate Extraction of Barrett's Esophagus Endoscopy Quality Metrics.medRxiv : the preprint server for health sciences · 2023Article
- Endoscopic Management of Barrett's Esophagus.Digestive diseases and sciences · 2022Review
- Advanced imaging and artificial intelligence for Barrett's esophagus: What we should and soon will do.World journal of gastroenterology · 2022Review
- Development of quality indicators for the diagnosis and management of achalasia.Neurogastroenterology and motility · 2021Article
- Comparative Cost Effectiveness of Reflux-Based and Reflux-Independent Strategies for Barrett's Esophagus Screening.The American journal of gastroenterology · 2021Article
- Survival outcomes for patients with four treatments in stages I-III esophageal squamous cell carcinoma: a SEER analysis.Translational cancer research · 2021Article
- Barrett's esophagus: current standards in advanced imaging.Translational gastroenterology and hepatology · 2021Review
- Screening for Barrett's Oesophagus: Are We Ready for it?Current treatment options in gastroenterology · 2021Review
- Radiofrequency Ablation of Barrett's Esophagus: Have We Gone Too Far, or Not Far Enough?Current gastroenterology reports · 2020Review
- Quality indicators in diagnostic upper gastrointestinal endoscopy.Therapeutic advances in gastroenterology · 2020Review
- Quality of Care Indicators in Patients with Acute Pancreatitis.Digestive diseases and sciences · 2019Article
- Screening for Barrett's Esophagus: Balancing Clinical Value and Cost-effectiveness.Journal of neurogastroenterology and motility · 2019Article
- Combined EsophaCap cytology and MUC2 immunohistochemistry for screening of intestinal metaplasia, dysplasia and carcinoma.Clinical and experimental gastroenterology · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
29 authors.
Funding
Abstract
The development of and adherence to quality indicators in gastroenterology, as in all of medicine, is increasing in importance to ensure that patients receive consistent high-quality care. In addition, government-based and private insurers will be expecting documentation of the parameters by which we measure quality, which will likely affect reimbursements. Barrett's esophagus remains a particularly important disease entity for which we should maintain up-to-date guidelines, given its commonality, potentially lethal outcomes, and controversies regarding screening and surveillance. To achieve this goal, a relatively large group of international experts was assembled and, using the modified Delphi method, evaluated the validity of multiple candidate quality indicators for the diagnosis and management of Barrett's esophagus. Several candidate quality indicators achieved >80% agreement. These statements are intended to serve as a consensus on candidate quality indicators for those who treat patients with Barrett's esophagus.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.